Antithrombin deficiency is associated with mortality and impaired organ function in septic pediatric patients: a retrospective study

被引:18
作者
Niederwanger, Christian [1 ]
Hell, Tobias [2 ]
Hofer, Sophie [3 ]
Salvador, Christina [4 ]
Michel, Miriam [5 ]
Schenk, Bettina [3 ]
Treml, Benedikt [3 ]
Bachler, Mirjam [6 ]
机构
[1] Med Univ Innsbruck, Intens Care Unit, Pediat 1, Dept Pediat, Innsbruck, Austria
[2] Univ Innsbruck, Fac Math Comp Sci & Phys, Dept Math, Innsbruck, Austria
[3] Med Univ Innsbruck, Dept Gen & Surg Crit Care Med, Innsbruck, Austria
[4] Med Univ Innsbruck, Dept Pediat, Pediat 1, Haematol & Oncol, Innsbruck, Austria
[5] Med Univ Innsbruck, Dept Pediat, Pediat 3, Cardiol, Innsbruck, Austria
[6] UMIT Univ Hlth Sci Med Informat & Technol, Dept Sports Med Alpine Med & Hlth Tourism, Hall In Tirol, Austria
来源
PEERJ | 2018年 / 6卷
关键词
Children; Antithrombin; Mortality; Sepsis; Organ failure; C-reactive protein; Threshold level; C-REACTIVE PROTEIN; HIGH-DOSE ANTITHROMBIN; DISSEMINATED INTRAVASCULAR COAGULATION; RESPIRATORY-DISTRESS-SYNDROME; CRITICALLY-ILL CHILDREN; ACUTE LIVER-FAILURE; SEVERE SEPSIS; DEVELOPMENTAL HEMOSTASIS; III PREVENTS; DOUBLE-BLIND;
D O I
10.7717/peerj.5538
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background. Sepsis remains a major problem in intensive care medicine. It is often accompanied by coagulopathies, leading to thrombotic occlusion of small vessels with subsequent organ damage and even fatal multi-organ failure. Prediction of the clinical course and outcome-especially in the heterogeneous group of pediatric patients-is difficult. Antithrombin, as an endogenous anticoagulant enzyme with anti-inflammatory properties, plays a central role in controling coagulation and infections. We investigated the relationship between antithrombin levels and organ failure as well as mortality in pediatric patients with sepsis. Methods. Data from 164 patients under the age of 18, diagnosed with sepsis, were retrospectively reviewed. Antithrombin levels were recorded three days before to three days after peak C-reactive protein to correlate antithrombin levels with inflammatory activity. Using the concept of developmental haemostasis, patients were divided into groups <1 yr and >= 1 yr of age. Results. In both age groups, survivors had significantly higher levels of antithrombin than did deceased patients. An optimal threshold level for antithrombin was calculated by ROC analysis for survival: 41.5% (<1 yr) and 67.5% (>= 1 yr). The mortality rate above this level was 3.3% (<1 yr) and 9.5% (>= 1 yr), and below this level 41.7% (<1 yr) and 32.2% (>= 1 yr); OR 18.8 (1.74 to 1005.02), p = 0.0047, and OR 4.46 (1.54 to 14.89), p = 0.003. In children < 1 yr with antithrombin levels < 41.5% the rate of respiratory failure (66.7%) was significantly higher than in patients with antithrombin levels above this threshold level (23.3%),OR 6.23 (1.23 to 37.81), p = 0.0132. In children >= 1 yr, both liver failure (20.3% vs 1.6%, OR 15.55 (2.16 to 685.01), p = 0.0008) and a dysfunctional intestinal tract (16.9% vs 4.8%, OR 4.04 (0.97 to 24.08), p = 0.0395) occurred more frequently above the antithrombin threshold level of 67.5%. Conclusion. In pediatric septic patients, significantly increased mortality and levels of organ failure were found below an age-dependent antithrombin threshold level. Antithrombin could be useful as a prognostic marker for survival and occurrence of organ failure in pediatric sepsis.
引用
收藏
页数:20
相关论文
共 76 条
[1]   Antithrombin III for critically ill patients: a systematic review with meta-analysis and trial sequential analysis [J].
Allingstrup, Mikkel ;
Wetterslev, Jorn ;
Ravn, Frederikke B. ;
Moller, Ann Merete ;
Afshari, Arash .
INTENSIVE CARE MEDICINE, 2016, 42 (04) :505-520
[2]   Coagulation in sepsis [J].
Amaral, A ;
Opal, SM ;
Vincent, JL .
INTENSIVE CARE MEDICINE, 2004, 30 (06) :1032-1040
[3]  
ANDREW M, 1988, BLOOD, V72, P1651
[4]   DEVELOPMENT OF THE HUMAN COAGULATION SYSTEM IN THE FULL-TERM INFANT [J].
ANDREW, M ;
PAES, B ;
MILNER, R ;
JOHNSTON, M ;
MITCHELL, L ;
TOLLEFSEN, DM ;
POWERS, P .
BLOOD, 1987, 70 (01) :165-172
[5]   MATURATION OF THE HEMOSTATIC SYSTEM DURING CHILDHOOD [J].
ANDREW, M ;
VEGH, P ;
JOHNSTON, M ;
BOWKER, J ;
OFOSU, F ;
MITCHELL, L .
BLOOD, 1992, 80 (08) :1998-2005
[6]  
[Anonymous], 2017, R LANG ENV STAT COMP
[7]   Age dependency of coagulation parameters during childhood and puberty [J].
Appel, I. M. ;
Grimminck, B. ;
Geerts, J. ;
Stigter, R. ;
Cnossen, M. H. ;
Beishuizen, A. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2012, 10 (11) :2254-2263
[8]   Developmental hemostasis: age-specific differences in the levels of hemostatic proteins [J].
Attard, C. ;
van der Straaten, T. ;
Karlaftis, V. ;
Monagle, P. ;
Ignjatovic, V. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 (10) :1850-1854
[9]  
Bartolovic Daniela, 2011, EJIFCC, V22, P24
[10]   Antithrombin III (ATIII) replacement therapy in patients with sepsis and/or postsurgical complications: a controlled double-blind, randomized, multicenter study [J].
Baudo, F ;
Caimi, TM ;
de Cataldo, F ;
Ravizza, A ;
Arlati, S ;
Casella, G ;
Carugo, D ;
Palareti, G ;
Legnani, C ;
Ridolfi, L ;
Rossi, R ;
D'Angelo, A ;
Crippa, L ;
Giudici, D ;
Gallioli, G ;
Wolfler, A ;
Calori, G .
INTENSIVE CARE MEDICINE, 1998, 24 (04) :336-342